Cargando…

Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc

Scope: Bleeding, the main drawback of clinically used chemical anti-thrombotic drug is resulted from the unidirectional suppression of platelet activity. Therefore, dual-directional regulatory effect on platelet is the main preponderance of Panax notoginseng over these drugs. The dual-directional re...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yingqiu, Liu, Tianyi, Ding, Kevin, Liu, Zengyuan, Li, Yuanyuan, He, Taotao, Zhang, Weimin, Fan, Yunpeng, Ma, Wuren, Cui, Li, Song, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232503/
https://www.ncbi.nlm.nih.gov/pubmed/30459626
http://dx.doi.org/10.3389/fphar.2018.01293
_version_ 1783370402847784960
author Liu, Yingqiu
Liu, Tianyi
Ding, Kevin
Liu, Zengyuan
Li, Yuanyuan
He, Taotao
Zhang, Weimin
Fan, Yunpeng
Ma, Wuren
Cui, Li
Song, Xiaoping
author_facet Liu, Yingqiu
Liu, Tianyi
Ding, Kevin
Liu, Zengyuan
Li, Yuanyuan
He, Taotao
Zhang, Weimin
Fan, Yunpeng
Ma, Wuren
Cui, Li
Song, Xiaoping
author_sort Liu, Yingqiu
collection PubMed
description Scope: Bleeding, the main drawback of clinically used chemical anti-thrombotic drug is resulted from the unidirectional suppression of platelet activity. Therefore, dual-directional regulatory effect on platelet is the main preponderance of Panax notoginseng over these drugs. The dual-directional regulatory effect should be ascribed to the resourceful Panax notoginseng saponins (PNS). Clarifying the mechanism of main PNS in both inhibiting and promoting platelet aggregation will give a full outlook for the dual-directional regulatory effect. The present study is aimed at explaining the mechanism of Notoginsenoside Fc (Fc), a main PNS, in inhibiting platelet aggregation. Methods: In the in vitro study, after incubating platelets with Fc and m-3M3FBS, platelet aggregation was triggered by thrombin, collagen or ADP. Platelet aggregation was measured by aggregometer. Phospholipase Cγ2 (PLCγ2) and protein kinase C (PKC) activities were studied by western blotting. Diacylglycerol (DAG), thromboxane B(2) (TXB(2)) and 1,4,5-inositol trisphosphate (IP(3)) concentrations were measured by corresponding ELISA kits. Calcium concentrations ([Ca(2+)]) were estimated through the fluorescence intensity emitted from Fluo-4. In the in vivo study, thrombus model was induced by FeCl(3). The effect of Fc on thrombosis was evaluated by measurement of protein content and observation of injured blood vessel. Results: thrombin, collagen and ADP induced platelet aggregation were all suppressed by incubating platelets with Fc. Platelet PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3) were down-regulated by Fc as well. However, the basal [Ca(2+)] in platelet was not altered by Fc. Nevertheless, thrombin triggered activation of PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3)-[Ca(2+)] were all abolished by Fc. Fc also attenuated platelet aggregation and PLCγ2 signaling activation induced by PLC activator, m-3M3FBS. In the in vivo study, FeCl(3) induced thrombosis in rat femoral artery was significantly alleviated by administration of Fc. Conclusion: The results above suggested the antiplatelet and antithrombotic effects of Fc are carried out through oppression of PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3)-[Ca(2+)]. The present study provided theoretical support for new anti-thrombotic drug exploitation by Panax notoginseng.
format Online
Article
Text
id pubmed-6232503
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62325032018-11-20 Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc Liu, Yingqiu Liu, Tianyi Ding, Kevin Liu, Zengyuan Li, Yuanyuan He, Taotao Zhang, Weimin Fan, Yunpeng Ma, Wuren Cui, Li Song, Xiaoping Front Pharmacol Pharmacology Scope: Bleeding, the main drawback of clinically used chemical anti-thrombotic drug is resulted from the unidirectional suppression of platelet activity. Therefore, dual-directional regulatory effect on platelet is the main preponderance of Panax notoginseng over these drugs. The dual-directional regulatory effect should be ascribed to the resourceful Panax notoginseng saponins (PNS). Clarifying the mechanism of main PNS in both inhibiting and promoting platelet aggregation will give a full outlook for the dual-directional regulatory effect. The present study is aimed at explaining the mechanism of Notoginsenoside Fc (Fc), a main PNS, in inhibiting platelet aggregation. Methods: In the in vitro study, after incubating platelets with Fc and m-3M3FBS, platelet aggregation was triggered by thrombin, collagen or ADP. Platelet aggregation was measured by aggregometer. Phospholipase Cγ2 (PLCγ2) and protein kinase C (PKC) activities were studied by western blotting. Diacylglycerol (DAG), thromboxane B(2) (TXB(2)) and 1,4,5-inositol trisphosphate (IP(3)) concentrations were measured by corresponding ELISA kits. Calcium concentrations ([Ca(2+)]) were estimated through the fluorescence intensity emitted from Fluo-4. In the in vivo study, thrombus model was induced by FeCl(3). The effect of Fc on thrombosis was evaluated by measurement of protein content and observation of injured blood vessel. Results: thrombin, collagen and ADP induced platelet aggregation were all suppressed by incubating platelets with Fc. Platelet PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3) were down-regulated by Fc as well. However, the basal [Ca(2+)] in platelet was not altered by Fc. Nevertheless, thrombin triggered activation of PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3)-[Ca(2+)] were all abolished by Fc. Fc also attenuated platelet aggregation and PLCγ2 signaling activation induced by PLC activator, m-3M3FBS. In the in vivo study, FeCl(3) induced thrombosis in rat femoral artery was significantly alleviated by administration of Fc. Conclusion: The results above suggested the antiplatelet and antithrombotic effects of Fc are carried out through oppression of PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3)-[Ca(2+)]. The present study provided theoretical support for new anti-thrombotic drug exploitation by Panax notoginseng. Frontiers Media S.A. 2018-11-06 /pmc/articles/PMC6232503/ /pubmed/30459626 http://dx.doi.org/10.3389/fphar.2018.01293 Text en Copyright © 2018 Liu, Liu, Ding, Liu, Li, He, Zhang, Fan, Ma, Cui and Song. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Yingqiu
Liu, Tianyi
Ding, Kevin
Liu, Zengyuan
Li, Yuanyuan
He, Taotao
Zhang, Weimin
Fan, Yunpeng
Ma, Wuren
Cui, Li
Song, Xiaoping
Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
title Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
title_full Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
title_fullStr Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
title_full_unstemmed Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
title_short Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
title_sort phospholipase cγ2 signaling cascade contribute to the antiplatelet effect of notoginsenoside fc
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232503/
https://www.ncbi.nlm.nih.gov/pubmed/30459626
http://dx.doi.org/10.3389/fphar.2018.01293
work_keys_str_mv AT liuyingqiu phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT liutianyi phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT dingkevin phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT liuzengyuan phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT liyuanyuan phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT hetaotao phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT zhangweimin phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT fanyunpeng phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT mawuren phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT cuili phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc
AT songxiaoping phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc